PAIA Biotech
Founded in 2014, PAIA Biotech has developed a growing portfolio of high-throughput assays for its patented detection technology using special microplates in small volumes.
PAIA´s developability assays have become a standard tool for wet lab validation of AI-driven antibody discovery work, because of its unmatched speed and data quality, which is required for today’s design-build-test cycles.
PAIA Biotech GmbH is based in the center of Europe, in Cologne/Germany.
